Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
00466
CAS Number:
22862-76-6
Anisomycin (from Streptomyces griseolus)
Purity:
≥ 98% (HPLC)
Synonym(s):
(2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate, Flagecidin
Hazmat
Antibiotic
Documents
$68.90 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information
Synonyms
(2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate, Flagecidin
CAS Number
22862-76-6
Purity
≥ 98% (HPLC)
Molecular Formula
C14H19NO4
Molecular Weight
0
MDL Number
MFCD00077650
PubChem ID
2199
Melting Point
140 - 143 ºC
Appearance
White crystalline powder
Conditions
Store at 0 - 8 °C
Warnings
Toxic!
General Information
Synonyms
(2R,3S,4S)-2-(4-Methoxybenzyl)-3,4-pyrrolidinediol-3-acetate, Flagecidin
CAS Number
22862-76-6
Purity
≥ 98% (HPLC)
Molecular Formula
C14H19NO4
Molecular Weight
0
MDL Number
MFCD00077650
PubChem ID
2199
Melting Point
140 - 143 ºC
Appearance
White crystalline powder
Conditions
Store at 0 - 8 °C
Warnings
Toxic!
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Yes
Antibiotic
Yes
DEA-regulated
No
Warnings
Toxic!
Applications

Anisomycin is widely utilized in research focused on:

  • Antibiotic Development: Anisomycin is known for its antimicrobial properties, making it a valuable compound in the development of new antibiotics to combat resistant bacterial strains.
  • Cell Biology Studies: Researchers use anisomycin to inhibit protein synthesis, allowing for the study of cellular responses to stress and the mechanisms of apoptosis in various cell types.
  • Neuroscience Research: This compound is employed in studies investigating synaptic plasticity and memory formation, providing insights into neurodegenerative diseases and cognitive disorders.
  • Plant Pathology: Anisomycin has applications in agriculture as a fungicide, helping to protect crops from fungal infections and improving yield in various agricultural practices.
  • Pharmaceutical Formulations: Its unique properties allow anisomycin to be explored in drug formulations aimed at enhancing the efficacy of existing treatments, particularly in cancer therapy.

Citations